The Future of Health Technology Regulation (www.kiu.ac.ug)

The rapid advancement of health technologies ranging from artificial intelligence-driven diagnostics to
wearable health devices and digital therapeutics has significantly outpaced the capacity of existing
regulatory frameworks. This paper explores the pressing need for adaptive, inclusive, and globally
coherent regulatory strategies that can respond to innovations while safeguarding public health. It
reviews the current landscape of health technology regulation, highlights the roles of key stakeholders,
and identifies challenges such as ethical concerns, governance fragmentation, and the mismatch between
regulatory speed and technological development. Case studies from the United States, Europe, and other
global regions underscore both the successes and limitations of existing models. The study advocates for
an innovation-responsive approach that balances regulatory rigor with flexibility, prioritizes patient
safety, ensures equitable access, and integrates ethical accountability. By mapping future directions and
global initiatives, the paper offers a policy roadmap for governments, researchers, and regulatory bodies
to align emerging technologies with public interest and sustainable health outcomes.

1. EEJOURNALS OPEN ACCESS
75







The Future of Health Technology Regulation

Mugo Moses H.
School of Natural and Applied Sciences Kampala International University Uganda
ABSTRACT
The rapid advancement of health technologies ranging from artificial intelligence-driven diagnostics to
wearable health devices and digital therapeutics has significantly outpaced the capacity of existing
regulatory frameworks. This paper explores the pressing need for adaptive, inclusive, and globally
coherent regulatory strategies that can respond to innovations while safeguarding public health. It
reviews the current landscape of health technology regulation, highlights the roles of key stakeholders,
and identifies challenges such as ethical concerns, governance fragmentation, and the mismatch between
regulatory speed and technological development. Case studies from the United States, Europe, and other
global regions underscore both the successes and limitations of existing models. The study advocates for
an innovation-responsive approach that balances regulatory rigor with flexibility, prioritizes patient
safety, ensures equitable access, and integrates ethical accountability. By mapping future directions and
global initiatives, the paper offers a policy roadmap for governments, researchers, and regulatory bodies
to align emerging technologies with public interest and sustainable health outcomes.
Keywords: Health technology regulation, artificial intelligence, digital health, medical devices, policy
frameworks, innovation, ethics in health tech.
INTRODUCTION
Health technologies are vital policy tools that play a crucial role in improving health outcomes by
effectively influencing health determinants, enhancing healthcare delivery, or addressing broader social
and economic conditions that impact public health. The rapid pace of development of new health
technologies and tools has far outstripped the capacity of various stakeholders to adequately regulate
them. This situation necessitates the establishment of a renewed and comprehensive framework for
regulation that can keep pace with advancements in the field. Regulatory frameworks can vary
significantly across different jurisdictions and among the various classes of technologies being considered.
Furthermore, the successful implementation of these regulations is highly dependent on the prevailing
attitudes and interests of regulators, policymakers, and governors involved. This framing paper not only
provides an overview of the current state-of-the-art technologies but also discusses emerging trends and
anticipated future developments in the field. It aims to outline a strategic roadmap for addressing key
issues that a design-oriented policy research agenda should systematically tackle. This work arises from
an ongoing and collaborative effort to create a robust framework for assessing and evaluating health
technologies effectively, ensuring they can be utilized to their fullest potential in promoting public health
and well-being [1, 2].
Current Landscape of Health Technology Regulation
Current health technology regulation frameworks comprehensively address the safety, quality, and
overall utility of devices that access sensitive patient data or influence critical clinical decisions. These
frameworks represent a significant evolution from the traditional medical device controls that were
predominantly focused on basic safety standards. They have transitioned to more sophisticated
approaches that are carefully calibrated according to design characteristics and various levels of patient
risk. In many countries, these regulatory frameworks are constituted by a combination of medical device
directives, pharmaceutical regulations, privacy and technological legislations, as well as a variety of
EURASIAN EXPERIMENT JOURNAL OF ENGINEERING
(EEJE) ISSN: 2992-409X
@EEJE PUBLICATIONS Volume 5 Issue 1 2025

2. EEJOURNALS OPEN ACCESS
76

voluntary standards. Consequently, regulations often extend across traditional healthcare providers,
along with the commercial rules that govern point-of-care marketing, and the comprehensive governance
of clinical research. However, despite these advancements, existing systems often relegate emerging
technologies to a process of adaptation by analogy, where new innovations are evaluated based on
outdated frameworks. Furthermore, the accommodation of completely novel concepts within these
regulatory systems remains quite uncommon, creating significant barriers for innovators. Divergent
implementations of these regulations frequently exacerbate issues of governance fragmentation, leading
to inconsistent oversight and potentially impacting the safe delivery of healthcare solutions [3, 4].
Key Stakeholders in Health Technology
Health technology includes products and services supporting health and healthcare, from wheelchairs to
mobile health apps. Developers aim to improve health outcomes using advanced materials and electrical
power, while larger systems enhance care providers' efficiency and decision-making. Beyond clinical
settings, sensors and smart systems aid in health monitoring and independent living. Regulation ensures
the safety and efficacy of health products, with various frameworks addressing specific components. For
instance, the FDA regulates drug development, while certification processes ensure market readiness,
following good manufacturing practices globally. The swift emergence of digital health tools poses
challenges for regulatory oversight, making it vital to assess if current frameworks are adequate or if new
methods are necessary. Societal and ethical considerations highlight the need for appropriate regulatory
standards. Health technology refers to organized knowledge and skills related to medicines, vaccines,
medical devices, and services aimed at improving health outcomes. It includes simple interventions like
wheelchairs and advanced innovations like pacemakers and health apps. Key stakeholders affect
regulatory strategies: regulators enforce standards and evaluate technologies; developers offer insights;
healthcare professionals engage with technologies in treatment; and patients generate data through
monitoring devices for prevention and rehabilitation [5, 6].
Emerging Trends in Health Technology
Emerging health technologies are reshaping care delivery by overcoming traditional limitations,
reimagining health systems, and creating global access. Artificial intelligence (AI) catalyzes enduring
changes in development, diagnosis, treatment, and outreach. Already part of many systems, AI
mechanisms detect cognitive impairment earlier, identify high-quality physicians, and enable new demand
and health patterns that require coordinated regulatory responses. Telemedicine’s rapid adoption depends
on expanding coverage, enabling multiple points of contact, and increasing confidence to convert initial
use into long-term behavioral change. User-controlled wearable devices, plug-and-play diagnostics,
multilevel transitions of care, and electronic health records are other emergent trends that promote
decentralization, empower consumers, and facilitate innovation [7, 8].
Challenges in Regulating Health Technologies
Health technologies include tools like wearables, telemedicine, and AI for diagnosis and patient care.
Their broad and multidisciplinary nature necessitates inclusive policy frameworks, as digital health is a
new field with varying country-specific strategies. Due to different health system conditions, a universal
approach is ineffective. Understanding the challenges countries face is key in policy development. Rapid
advancements in health technology pose challenges for global regulatory bodies, with unknown side
effects and malfunction risks even for effective innovations. Regulatory processes often cannot match the
swift pace of innovation, leading to potential patient safety risks. Moreover, a lack of interoperability
among regulatory frameworks undermines global efficiency, with varying regulations governing digital
health products. Ensuring cybersecurity is also a critical concern, as regulators seek to balance patient
protection with innovation encouragement while monitoring side effects. The use of connected
technologies raises significant data security and privacy challenges, as handling sensitive information may
infringe on individual rights. Effective regulation must tackle issues like data ownership, sharing, and
interoperability to safeguard privacy while enabling technological integration. Additionally, the
proliferation of diverse devices restricts practical application, while outdated infrastructures hinder the
integration of new technologies, complicating information sharing across regions and organizations [9,
10].
Global Perspectives on Health Technology Regulation
Multinational Comparison of Regulatory Frameworks the USA, EU, and UK have significantly led the
way in creating a set of harmonized principles specifically for AI-enabled medical devices, thus providing
a detailed blueprint that aims to guide the international community in the pursuit of effective regulation.
Essén et al. conduct a thorough analysis of national policies across nine developed countries, revealing a
complex patchwork of programs characterized by varying maturity levels. This highlights the pressing

3. EEJOURNALS OPEN ACCESS
77

necessity for centralized mechanisms that effectively address both market access and reimbursement
challenges in the healthcare sector. Regional and National Focus In this evolving landscape, extensive
and innovative policy initiatives have emerged across the globe. Notable examples include Singapore’s
Health Services Research Act, which aims to enhance the quality and accessibility of health services,
Israel’s Ministry of Health Digital Health Strategy that focuses on advancing digital health technologies,
the FDA’s Digital Health Innovation Action Plan that seeks to streamline the regulatory process for
digital health products, Saudi Arabia’s National Digital Transformation Strategy that emphasizes
modernizing healthcare through digital solutions, and the UK’s Technology Code of Practice, which
offers guidelines for responsible technology use in health. These diverse and comprehensive efforts
underscore a global sense of urgency and a shared commitment to balanced and effective regulation in the
rapidly changing healthcare landscape [11, 12].
Case Studies of Health Technology Regulation
Prominent examples illustrate ongoing and enduring challenges in accurately calibrating and fine-tuning
regulatory controls for various novel and innovative products that have emerged. The United States
government initially imposed strict restrictions on the import and use of the pacemaker, driven by fears of
potential self-inflicted harm that could arise from its use. However, after facing untenable delays in
obtaining this crucial medical device, the Food and Drug Administration (FDA) ultimately authorized
pacemakers for manufacturing and distribution within the United States. Meanwhile, in Europe, the
Theranos blood testing kit emerged as an emblematic example of vast commercial promises being made
without sufficient verification of both performance and safety claims. Regulatory officials moved to
disqualify the company's data and took legal action to prosecute the organization’s leadership for
committing fraud against investors and various health facilities. As seen in many other domains and
industries, the accreditation of bodies that are authorized to conduct conformity assessments requires
significantly more development and improvement to ensure public trust and safety [13, 14].
The Role of Innovation in Regulation
Current regulatory frameworks largely address established health technologies. New innovations
challenge the scope and catch-all approach of existing regimes. Political priorities and growing regulatory
science capabilities increasingly shape boundaries between sectors, further complicating regulation.
Besides crafting regulations, innovations enable regulators to detect non-compliance and manage large
code bases. Artificial intelligence determines whether interventions meet medical device definitions and
monitors clinical data, exemplifying how innovation aids regulatory decision-making. Technological
progress accelerates the emergence of new innovations, outpacing the capacity of regulators and industry
stakeholders to adapt. Authorities must reconcile stability avoiding regulatory disruptions that could
impact public health and intended outcomes and flexibility, as over-complex safeguards may deter the
adoption of novel technologies. Public intervention serves as the primary mechanism for managing
negative externalities and market failures. Regulations thus delineate boundaries and establish rules of
play that align with the public interest while preserving political legitimacy. Remaining responsive to
innovation addresses ethical, societal, and dual-use concerns [15, 16].
Future Directions for Health Technology Regulation
Despite the considerable challenges presented by health technologies, opportunities abound for
policymakers. As AI and associated tools begin to match or outperform human experts, regulations must
strive to enable technology that ensures cheaper, faster, and more equitable delivery around the world,
rather than hindering the type of innovation that could fundamentally improve quality and access.
Moreover, the absence of a globally agreed approach leaves space for policymakers to shape the future of
digital health regulation. Efforts during the COVID-19 pandemic to rapidly deploy new technologies on
exceptionally fast timelines illustrate the potential for ultra-light-touch regulatory strategy. While most
experts regarded such an approach as unjustifiable in normal circumstances, the very real value of
technology during the pandemic may encourage reconsideration of traditional approaches for non-
pandemic use cases. Hence there is room for a nuanced balance between fostering innovation and
ensuring quality and equity, signaling fruitful opportunities for scientists and policymakers alike [17, 18].
Ethical Considerations in Health Technology
Policymakers and the scientific community emphasize the necessity of addressing ethical implications
associated with health technologies. Concerns regarding privacy, fairness, bias, accountability and
transparency, and safety are increasingly prevalent. Examples of ethical challenges include the inability of
wearable technologies to share context necessary to establish true medical meaning and the variable
quality of various telehealth and mHealth offerings. Facilitating ethical decision-making requires
environmental shifts at societal, corporate, governmental, and research-policy levels. While regulations

4. EEJOURNALS OPEN ACCESS
78

are aligned to uphold existing ethical guidelines, such as privacy and beneficence, several policy areas
require greater attention. Achieving equitable benefits from AI advances depends not only on scientific
and technological challenges but also on understanding and mitigating biases within the system. The
ability to evaluate and hold automated systems accountable for the quality of their outputs is essential, yet
transparency is generally absent, partly due to concerns about protecting intellectual property. A
regulatory regime informed by public consultation, co-designed guidelines with practitioners, and
sustained planning offers a framework for governing emerging health and social technologies that
presents acceptable risks, delivers maximum benefits, protects citizens, and provides recourse when
harms occur. Careful consideration of regulatory approaches for health and social data-driven
technologies is necessary, alongside or in support of other forms of governance such as ethical
frameworks, transparency standards, co-regulatory mechanisms, and industry-specific guidance.
Recognition persists that formal regulations constitute only one instrument among many for providing
guidance to developers, industry, and users [19, 20].
Impact of Covid-19 on Health Technology Regulation
The COVID-19 pandemic has accelerated the adoption and development of health technologies and
prompted regulatory authorities to update existing approval pathways or implement new ones. The use of
additional tools to support clinical trials, such as telemedicine, remote monitoring, real-world evidence,
and artificial intelligence, further underlines how the health-care sector, policy makers, and regulators
leveraged new approaches to demonstrate that innovation and regulation can coexist. However,
government oversight keeps a fundamental role, and once the crisis is passed, the policy agenda may
return to its previous course, reflecting a policy environment that seeks to ensure public access, safety and
efficacy. Whether regulatory initiatives introduced during the emergency will survive beyond the lesson
of the pandemic remains to be seen, but policy and regulation clearly represent two of the great levers to
reshape the health-care ecosystem. The COVID-19 pandemic has exposed the fragility of health-care
supply chains and given new impetus to the development and adoption of health technologies. The crisis
has also motivated regulatory authorities to accelerate their decision-making processes and recalibrate
their approvēal pathways. New initiatives drafted to respond to unique circumstances accompanied this
environment and probably will continue beyond the emergency [21, 22].
Policy Recommendations for Future Regulation
A range of recommendations emerge for policymakers striving to secure a robust and dynamic regulatory
environment that balances the opportunity of innovation with the imperative of safeguarding patient
wellbeing. Health technology regulatory systems should be adaptable to rapid advances in both health
technologies and associated business models. Convergence, interoperability and sharing of data among
systems, developers, manufacturers and their customers could also be encouraged. Any requirements for
research and development to be incorporated within regulatory frameworks should be supported by
strong incentives for companies. Space should be made for small changes, which incrementally improve
technologies, services and programmes. Harmonization and consistency of regulation at international
level could help prevent duplication of efforts; support and cooperation between regulators of a health
ecosystem could further increase efficiency, and automation in regulatory processes could also increase
speed and reduce costs. Moreover, regulators should be sufficiently funded and skilled to be able to
monitor and act upon emerging initiatives; early and meaningful engagement with developers, providers
and users of digital health technologies could facilitate this as well as improving the regulation of health
technologies [23, 24].
CONCLUSION
As health technologies continue to evolve at unprecedented rates, traditional regulatory models risk
becoming obsolete, creating gaps in oversight and undermining public trust. Effective regulation must
now be seen not only as a tool to enforce compliance but as a dynamic system that fosters responsible
innovation. Future frameworks should emphasize flexibility, interoperability, and cross-sector
collaboration, while integrating ethical principles such as transparency, equity, and data protection. The
lessons learned from global case studies and pandemic-era regulatory agility reveals the potential of
adaptive governance to support both technological progress and public safety. Policymakers must seize
the opportunity to co-create future-ready, participatory, and inclusive regulatory environments that
harness the full potential of health technology to improve lives across borders.
REFERENCES
1. Diao JA, Venkatesh KP, Raza MM, Kvedar JC. Multinational landscape of health app policy:
toward regulatory consensus on digital health. NPJ Digital Medicine. 2022 May 11;5(1):61.

5. EEJOURNALS OPEN ACCESS
79

2. Zhou K, Gattinger G. The evolving regulatory paradigm of AI in MedTech: a review of
perspectives and where we are today. Therapeutic Innovation & Regulatory Science. 2024
May;58(3):456-64.
3. Henshall C, Schuller T. Health technology assessment, value-based decision making, and
innovation. International journal of technology assessment in health care. 2013 Oct;29(4):353-9.
4. Albuquerque de Almeida F, Ricardo M. Different regulatory framework for medical devices and
drugs in the European Union: Impact on clinical research and health technology assessments.
The International journal of health planning and management. 2023 Sep;38(5):1420-34.
wiley.com
5. Barbazzeni B, Haider S, Friebe M. Engaging through awareness: purpose-driven framework
development to evaluate and develop future business strategies with exponential technologies
toward healthcare democratization. Frontiers in public health. 2022 May 25;10:851380.
6. Landers C, Blasimme A, Vayena E. Sync fast and solve things—best practices for responsible
digital health. npj Digital Medicine. 2024 May 4;7(1):113.
7. Aminabee S. The future of healthcare and patient-centric care: Digital innovations, trends, and
predictions. InEmerging technologies for health literacy and medical practice 2024 (pp. 240-
262). IGI Global Scientific Publishing. [HTML]
8. Ullah H, Manickam S, Obaidat M, Laghari SU, Uddin M. Exploring the potential of metaverse
technology in healthcare: Applications, challenges, and future directions. IEEE Access. 2023 Jun
15;11:69686-707. ieee.org
9. Malichenko VS. International Law Regulation on Access to Health Technologies. Legal Issues
Digit. Age. 2021;2:126.
10. World Health Organization. Health technology assessment of medical devices. World Health
Organization; 2025 May 30.
11. Rimpi, Verma SJ, Pinky, Baldi A. Evidence-based recommendations for comprehensive
regulatory guidelines in medical devices: the imperative for global harmonization. Naunyn-
Schmiedeberg's Archives of Pharmacology. 2025 Feb 5:1-5. [HTML]
12. Li P, Williams R, Gilbert S, Anderson S. Regulating AI/ML-enabled Medical Devices in the UK.
InProceedings of the First International Symposium on Trustworthy Autonomous Systems 2023
Jul 11 (pp. 1-10). [HTML]
13. Fraser AG, Redberg RF, Melvin T. The Origins of Regulations for Pharmaceutical Products and
Medical Devices–What Can be Learned for the Governance of Medical Devices in Europe?.
European Review. 2025 May 26:1-34.
14. Chettri B, Ravi R. A comparative study of medical device regulation between countries based on
their economies. Expert Review of Medical Devices. 2024 Jun 2;21(6):467-78.
15. Kasoju N, Remya NS, Sasi R, Sujesh S, Soman B, Kesavadas C, Muraleedharan CV, Varma PH,
Behari S. Digital health: trends, opportunities and challenges in medical devices, pharma and bio-
technology. CSI Transactions on ICT. 2023 Apr;11(1):11-30. springer.com
16. Mbunge E, Muchemwa B, Jiyane SE, Batani J. Sensors and healthcare 5.0: transformative shift in
virtual care through emerging digital health technologies. Global Health Journal. 2021 Dec
1;5(4):169-77.
17. Schmitt L. Mapping global AI governance: a nascent regime in a fragmented landscape. AI and
Ethics. 2022 May;2(2):303-14.
18. Qudus L. Cybersecurity governance: Strengthening policy frameworks to address global
cybercrime and data privacy challenges. International Journal of Science and Research Archive.
2025 Jan 30;14(1):1146-63. scholarsrepository.com
19. World Health Organization. Health technology assessment of medical devices. World Health
Organization; 2025 May 30.
20. Elendu C, Amaechi DC, Elendu TC, Jingwa KA, Okoye OK, Okah MJ, Ladele JA, Farah AH,
Alimi HA. Ethical implications of AI and robotics in healthcare: A review. Medicine. 2023 Dec
15;102(50):e36671. lww.com
21. Wamsley D, Chin-Yee B. COVID-19, digital health technology and the politics of the
unprecedented. Big Data & Society. 2021 May;8(1):20539517211019441.
22. Majeed A, Zhang X. On the adoption of modern technologies to fight the COVID-19 pandemic: a
technical synthesis of latest developments. COVID. 2023 Jan 16;3(1):90-123.
23. World Health Organization. Health technology assessment of medical devices. World Health
Organization; 2025 May 30.

6. EEJOURNALS OPEN ACCESS
80

24. ElZarrad MK, Lee AY, Purcell R, Steele SJ. Advancing an agile regulatory ecosystem to respond
to the rapid development of innovative technologies. Clinical and Translational Science. 2022
Jun;15(6):1332-9. wiley.com

CITE AS: Mugo Moses H. (2025). The Future of Health Technology
Regulation. EURASIAN EXPERIMEN T JOURNAL OF
ENGINEERING, 5(1):75-80.